Cargando…

Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery

There is a paucity of definitive evidence that supports the use of enoxaparin to prevent venous thromboembolism (VTE) after urologic laparoscopic surgery. The purpose of this study was to evaluate the efficacy and safety of postoperative subcutaneous enoxaparin injection in patients who underwent ur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomura, Takeo, Takahashi, Mika, Iwasaki, Kazunori, Oribe, Tomoya, Shinohara, Mayuka, Fukuda, Yuko, Mizoguchi, Shinsuke, Sato, Fuminori, Mimata, Hiromitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684086/ https://www.ncbi.nlm.nih.gov/pubmed/23819064 http://dx.doi.org/10.1155/2013/415918

Ejemplares similares

Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
por: Woo, Hee Doo, et al.
Publicado: (2013)

Laparoendoscopic Single-Site (LESS) Retroperitoneal Radical Nephrectomy in a Patient with Renal Cell Carcinoma Receiving Hemodialysis
por: Nomura, Takeo, et al.
Publicado: (2011)

Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019)

Laparoscopic ileal ureteral replacement to preserve the natural anti‐reflux system: An initial case report
por: Shinohara, Mayuka, et al.
Publicado: (2021)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

A Rare Case of Hernia Incarceration Under the Closed Port-Site Fascia After Robot-Assisted Laparoscopic Radical Cystectomy: Insights and Management Strategies
por: Hata, Shinro, et al.
Publicado: (2023)

GATA‐3 expression in primary pure choriocarcinoma of the bladder
por: Shinohara, Mayuka, et al.
Publicado: (2020)

Lymphoepithelioma-Like Carcinoma of the Bladder: A Case Report and Review of the Literature
por: Mori, Kenichi, et al.
Publicado: (2013)

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
por: Dybdahl, Daniel, et al.
Publicado: (2019)

Focal Therapy in the Management of Prostate Cancer: An Emerging Approach for Localized Prostate Cancer
por: Nomura, Takeo, et al.
Publicado: (2012)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Left Transperitoneal Adrenalectomy with a Laparoendoscopic Single-Site Surgery Combined Technique: Initial Case Reports
por: Sumino, Yasuhiro, et al.
Publicado: (2011)

Bemiparin versus Enoxaparin in the Prevention of Venous Thromboembolism among Intensive Care Unit Patients
por: Abbas, Mohamed Sayed
Publicado: (2017)

The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
por: Altawil, Esraa, et al.
Publicado: (2022)

742 Evaluation of Anti-Xa Levels and Venous Thromboembolism Prophylaxis with Enoxaparin in Burn Patients
por: Boyd, Allison, et al.
Publicado: (2023)

External iliac arterial dissection after robot‐assisted radical cystectomy with an intracorporeal ileal conduit and extended pelvic lymph node dissection
por: Nakashima, Syunsuke, et al.
Publicado: (2023)

Uretero-Internal Pudendal Artery Fistula with Longterm Indwelling of Ureteral Stent: A Case Report
por: Yuki, Hideo, et al.
Publicado: (2012)

Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells
por: SATO, RYUTA, et al.
Publicado: (2015)

A Case of Large Solitary Fibrous Tumor in the Retroperitoneum
por: Nomura, Takeo, et al.
Publicado: (2009)

Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
por: Bauersachs, Rupert M, et al.
Publicado: (2014)

Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer: A meta-analysis
por: Xing, Jiali, et al.
Publicado: (2018)

Ethical Concerns Regarding High-Dose Enoxaparin for Venous Thromboembolism Prevention in Plastic Surgery Patients
por: Swanson, Eric
Publicado: (2019)

Chronic hypoxia‐induced slug promotes invasive behavior of prostate cancer cells by activating expression of ephrin‐B1
por: Iwasaki, Kazunori, et al.
Publicado: (2018)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
por: Pineo, Graham F, et al.
Publicado: (2012)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Reduced dosing of enoxaparin for venous thromboembolism in overweight and obese adolescents: a single institution retrospective review
por: Hoffman, Stephanie, et al.
Publicado: (2017)

Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis
por: Huang, Hai-Feng, et al.
Publicado: (2018)

Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients
por: Al Otaib, Nouf, et al.
Publicado: (2017)

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
por: Zachariah, Seeba, et al.
Publicado: (2020)

Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran
por: Abutorabi, Ali, et al.
Publicado: (2023)

A case of retroperitoneal venous malformation resected by laparoscopic surgery
por: Fujinami, Hiroyuki, et al.
Publicado: (2022)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
por: Levitan, Bennett, et al.
Publicado: (2014)

Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial
por: Mirdamadi, Ahmad, et al.
Publicado: (2014)

Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
por: Drago, Filippo, et al.
Publicado: (2020)

Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia
por: Nomura, Takeo, et al.
Publicado: (2013)

Improving venous thromboembolism risk assessment rates in a tertiary urology department
por: Mabey, Elizabeth, et al.
Publicado: (2017)

In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism
por: Mitropoulou, Athanasia, et al.
Publicado: (2022)

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement
por: Dranitsaris, George, et al.
Publicado: (2011)

Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
por: Fuji, Takeshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nmptivb6qmi0lj0qbpitm97rqh